88327598 - PAIGE

Information

  • Trademark
  • 88327598
  • Serial Number
    88327598
  • Filing Date
    March 06, 2019
    5 years ago
  • Transaction Date
    March 29, 2019
    5 years ago
  • Status Date
    March 18, 2019
    5 years ago
  • Location Date
    March 09, 2019
    5 years ago
  • Status Code
    601
  • Current Location
    NEW APPLICATION PROCESSING
  • Attorney Docket Number
    126772-4000
    Attorney Name
    Jason S. Howell
  • Owners
Mark Drawing Code
4000
Mark Identification
PAIGE
Case File Statements
  • GS0091: Software, namely, computer programs for artificial intelligence, machine learning, deep learning, statistical learning, data mining, and contextual prediction; software for use in disease pathology, namely, software that reads digital slides and provides diagnoses; software for use in evaluation of prognosis relating to diseases, states, or conditions; software for use in monitoring of diseases, states, or conditions; software for use to detect or identify predispositions to diseases, states, or conditions; software for use to detect or determine the recurrence of diseases, states, or conditions; software for use to detect, monitor, or evaluate patients' responses to treatment of diseases, states, or conditions; software for use in clinical management of diseases, states, or conditions; software for use in the selection of treatment for diseases, states, or conditions; software for use in prevention of diseases, states, or conditions, namely, software that reviews and analyzes clinical pathology slides, and identifies measures to prevent future disease development; software for use in palliation or treatment of diseases, states or conditions; software for use in research or development in the field of life sciences; software for use in research or development in the field of medicine; software for use in research or development in the field of healthcare; software for use in research or development in the field of cancer; software for use in research or development in the field of oncology; software for use in research or development in the field of pathology
  • GS0421: Software as a service (SaaS) services featuring software for artificial intelligence, machine learning, deep learning, statistical learning, data mining, and contextual prediction; software as a service (SaaS) services featuring software for use in disease pathology, namely, software that reads digital slides and provides diagnoses; software as a service (SaaS) services featuring software for use in diagnosis of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in evaluation of prognosis relating to diseases, states, or conditions; software as a service (SaaS) services featuring software for use in monitoring of diseases, states, or conditions; software as a service (SaaS) services featuring software for use to detect or identify predispositions to diseases, states, or conditions; software as a service (SaaS) services featuring software to detect the recurrence of diseases, states, or conditions; software as a service (SaaS) services featuring software to detect, monitor, or evaluate patients' responses to treatment of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in clinical management of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in the selection of treatment of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in prevention of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in palliation or treatment of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in research or development in the field of life sciences; software as a service (SaaS) services featuring software for use in research or development in the field of medicine; software as a service (SaaS) services featuring software for use in research or development in the field of healthcare; software as a service (SaaS) services featuring software for use in research or development in the field of cancer; software as a service (SaaS) services featuring software for use in research or development in the field of oncology; software as a service (SaaS) services featuring software for use in research or development in the field of pathology; design and development of AI-powered computer software that analyzes clinical pathology slides and diagnoses diseases; medical research; scientific research and development services in the field of pathology; research and development services in the field of medicine; research and development services in the field of cancer; research and development services in the field of healthcare; research and development services in the field of life sciences; research and development services in the field of oncology; medical and scientific research services in the field of pathology; medical and scientific research services in the field of cancer; medical and scientific research services in the field of healthcare; medical and scientific research services in the field of life sciences; medical and scientific research services in the field of oncology; research and development of technology in the field of pathology; research and development of technology in the field of medicine; research and development of technology in the field of cancer; research and development of technology in the field of healthcare; research and development of technology in the field of life sciences; research and development of technology in the field of oncology; providing medical research and scientific research information via the internet; electronic scanning of clinical pathology slides; software as a service services (SaaS) featuring software for use in the analysis of clinical pathology slides; medical and scientific testing services for research purposes
  • GS0441: Medical services; cancer therapy services; medical testing, namely, the review and analysis of patients' clinical slides to identify additional recommended medical testing; medical testing for the diagnosis of diseases, states, or conditions; medical testing for evaluation of prognosis relating to diseases, states, or conditions; medical testing for the monitoring of diseases, states, or conditions; medical testing to detect or identify predispositions to diseases, states, or conditions; medical testing to detect or determine the recurrence of diseases, states, or conditions; medical testing to detect, monitor, or evaluate responses to treatment of diseases, states, or conditions; medical testing to evaluate clinical management of diseases, states, or conditions; medical testing for selection of treatment for diseases, states, or conditions; medical testing to evaluate or facilitate prevention of diseases, states, or conditions; medical testing to select, facilitate, monitor, or evaluate palliation or treatment of diseases, states or conditions; medical testing in the field of cancer; medical testing in the field of oncology; medical diagnostic testing, monitoring, or reporting services; medical analysis or advisory services in the field of cancer; medical analysis or advisory services in the field of oncology; medical analysis or advisory services for medical treatment; medical analysis or advisory services for the diagnosis of diseases, states, or conditions; medical analysis or advisory services for the evaluation of prognosis relating to diseases, states, or conditions; medical analysis or advisory services relating to monitoring diseases, states, or conditions; medical analysis or advisory services relating to the detection or identification of predispositions to diseases, states, or conditions; medical analysis or advisory services relating to the detection or determination of the recurrence of diseases, states, or conditions; medical analysis or advisory services relating to the detection, monitoring, or evaluation of responses to treatment of diseases, states, or conditions; medical analysis or advisory services relating to the clinical management of diseases, states, or conditions; medical analysis or advisory services relating to the selection of treatment for diseases, states, or conditions; medical analysis or advisory services relating to the prevention of diseases, states, or conditions; medical analysis or advisory services relating to the palliation or treatment of diseases, states or conditions; qualitative image analysis in the field of digital pathology for medical purposes; quantitative image analysis in the field of digital pathology for medical purposes; providing non-research related medical information via the internet; medical analysis services for the diagnosis of cancer by reviewing pathological samples on slides
Case File Event Statements
  • 3/24/2019 - 5 years ago
    5 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 3/18/2019 - 5 years ago
    4 - ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT Type: MAB1
  • 3/18/2019 - 5 years ago
    3 - ABANDONMENT - EXPRESS MAILED Type: ABN1
  • 3/15/2019 - 5 years ago
    2 - TEAS EXPRESS ABANDONMENT RECEIVED Type: EXAR
  • 3/9/2019 - 5 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP